| Q47915520 | A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment. |
| Q37206702 | A bioinformational systems perspective on tobacco dependence |
| Q34516895 | Acute effects of low and high dose alcohol on smoking lapse behavior in a laboratory analogue task |
| Q90128948 | Addiction and Voluntariness: Five "Challenges" to Address in Moving the Discussion Forward |
| Q36955420 | Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial |
| Q33945778 | Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment |
| Q47645212 | An examination of the cocaine relapse process |
| Q48694079 | Attitudes, subjective norm, perceived behavioral control, and intentions related to adult smoking cessation after coronary artery bypass graft surgery |
| Q35689374 | Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization |
| Q52141235 | Chronic addiction relapse treatment: a study of the effectiveness of the high-risk identification and prediction treatment model. Part I. |
| Q88971660 | Developing a laboratory model of smoking lapse targeting stress and brief nicotine deprivation |
| Q37294505 | Developing human laboratory models of smoking lapse behavior for medication screening |
| Q91667267 | Do Drinking and Smoking Go Together? |
| Q73795234 | Drinking as a risk factor for sustained smoking |
| Q36047868 | Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. |
| Q33820862 | Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration |
| Q27315099 | Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis |
| Q44415034 | Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats |
| Q48117764 | Event-related brain potentials as indicators of smoking cue-reactivity |
| Q41097697 | Experimental model of smoking re-exposure: effects on relapse |
| Q54968860 | Experimentally induced states of mind determine abstinent smokers' level of craving in reaction to smoking-cues. |
| Q30390711 | Gender differences in affective response to acute nicotine administration and deprivation. |
| Q37316011 | Influence of affective manipulations on cigarette craving: a meta-analysis. |
| Q48782893 | Is Marlatt's relapse taxonomy reliable or valid? |
| Q37063724 | Is self-efficacy for smoking abstinence a cause of, or a reflection on, smoking behavior change? |
| Q41196584 | Issues in relating self-efficacy to smoking relapse: importance of an "Achilles' heel" situation and of prior quitting experience |
| Q44573726 | Methodological note: Corroboration of self-reported smoking status using significant other reports |
| Q33821440 | Modeling the effect of alcohol on smoking lapse behavior |
| Q69140571 | Negative affect smoking and smoking relapse |
| Q48490512 | Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments |
| Q33844562 | Neural substrates of alcohol-induced smoking urge in heavy drinking nondaily smokers. |
| Q35142071 | Outcome predictors in substance use disorders |
| Q37249093 | Peer pressure, psychological distress and the urge to smoke |
| Q36462579 | Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment |
| Q48782960 | Predictive validity of Marlatt's relapse taxonomy versus a more general relapse code |
| Q33575373 | Progressive commercial cigarette yield reduction: biochemical exposure and behavioral assessment |
| Q33975327 | Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. |
| Q36818246 | Relations of alcohol consumption with smoking cessation milestones and tobacco dependence |
| Q86677956 | Relationship of self-effecacy to cholesterol lowering and dietary change in hyperlipidemia |
| Q51056227 | Response to social stress, urge to smoke, and smoking cessation. |
| Q37392398 | Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder |
| Q44261145 | Role of naltrexone in initial smoking cessation: preliminary findings |
| Q36942873 | Sex differences in stimulus expectancy and pharmacologic effects of a moderate dose of alcohol on smoking lapse risk in a laboratory analogue study. |
| Q36757495 | Shaping smoking cessation in hard-to-treat smokers |
| Q35947187 | Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes |
| Q82854007 | Spousal and alcohol-related predictors of smoking cessation: a longitudinal study in a community sample of married couples |
| Q36798820 | Stress decreases the ability to resist smoking and potentiates smoking intensity and reward |
| Q61798012 | The QuitIT Coping Skills Game for Promoting Tobacco Cessation Among Smokers Diagnosed With Cancer: Pilot Randomized Controlled Trial |
| Q52271395 | The drug avoidance self-efficacy scale |
| Q35951674 | The natural history of quitting smoking: findings from the International Tobacco Control (ITC) Four Country Survey |
| Q35017954 | The relationship between self-efficacy and reductions in smoking in a contingency management procedure |
| Q71231049 | [Tobacco and women] |